ArticleBMC cancer2018

Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPARγ/PTEN/mTOR signaling pathway.

Xinghao Ai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.